Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Elife
|
December 20, 2017
Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein
Ismael Al-Ramahi, Sai Srinivas Panapakkam Giridharan, Yu-Chi Chen, et al.
The Journal of Biological Chemistry
|
April 24, 2014
Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration
Aaron B Krueger, David J Drasin, Wendy A Lea, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2008
Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity
Stanley D Chamberlain, Anikó M Redman, Joseph W Wilson, et al.
Journal of Medicinal Chemistry
|
September 16, 2025
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer Cells
Ke Kong, Wei Zhao, Jonathan H Shrimp, et al.
Molecular Cancer Therapeutics
|
July 10, 2019
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells
Jothi Anantharajan, Hengbo Zhou, Lingdi Zhang, et al.
Cancer Research
|
April 29, 2020
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis
Hengbo Zhou, Melanie A Blevins, Jessica Y Hsu, et al.
Journal of Medicinal Chemistry
|
June 13, 2022
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis
Kevin J Frankowski, Samarjit Patnaik, Chen Wang, et al.
Nature
|
July 23, 2025
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity
Janna Heide, Agnes J Bilecz, Samarjit Patnaik, et al.
Journal of Medicinal Chemistry
|
April 6, 2021
Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer
Jason M Rohde, Surendra Karavadhi, Rajan Pragani, et al.
Nature Cancer
|
March 14, 2023
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers
Lei Shi, William Shen, Mindy I Davis, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Elife
|
December 20, 2017
Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein
Ismael Al-Ramahi, Sai Srinivas Panapakkam Giridharan, Yu-Chi Chen, et al.
The Journal of Biological Chemistry
|
April 24, 2014
Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration
Aaron B Krueger, David J Drasin, Wendy A Lea, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2008
Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity
Stanley D Chamberlain, Anikó M Redman, Joseph W Wilson, et al.
Journal of Medicinal Chemistry
|
September 16, 2025
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer Cells
Ke Kong, Wei Zhao, Jonathan H Shrimp, et al.
Molecular Cancer Therapeutics
|
July 10, 2019
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells
Jothi Anantharajan, Hengbo Zhou, Lingdi Zhang, et al.
Cancer Research
|
April 29, 2020
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis
Hengbo Zhou, Melanie A Blevins, Jessica Y Hsu, et al.
Journal of Medicinal Chemistry
|
June 13, 2022
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis
Kevin J Frankowski, Samarjit Patnaik, Chen Wang, et al.
Nature
|
July 23, 2025
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity
Janna Heide, Agnes J Bilecz, Samarjit Patnaik, et al.
Journal of Medicinal Chemistry
|
April 6, 2021
Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer
Jason M Rohde, Surendra Karavadhi, Rajan Pragani, et al.
Nature Cancer
|
March 14, 2023
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers
Lei Shi, William Shen, Mindy I Davis, et al.
Page
of 7